![](/images/graphics-bg.png)
An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation
Joint Authors
Futyma, Konrad
Miotła, Paweł
Gałczyński, Krzysztof
Baranowski, Włodzimierz
Doniec, Jacek
Wodzisławska, Agnieszka
Jóźwik, Maciej
Oniszczuk, Małgorzata
Rechberger, Tomasz
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-04-20
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
The prevalence of stress urinary incontinence rises and affects up to 30% of women after 50 years of age.
Midurethral slings are currently the mainstay of surgical anti-incontinence therapy.
Some patients experience recurrent SUI (RSUI) which is defined as a failure of anti-incontinence surgery after a period of time or persistence of SUI after the procedure aimed at correcting it.
The urethral bulking agent application decreases invasiveness of treatment and meets patients requirements.
The objective of this study was to assess the safety and clinical efficacy of Urolastic injection.
One hundred and five patients with SUI (including 91 patients with RSUI) were treated with Urolastic in three tertiary gynecological clinics.
The efficacy of the procedure was assessed objectively at each follow-up visit by means of cough test and a standard 1-hour pad test.
Objective success rate after 12 months after primary procedure in RSUI patients was found in 59.3% of patients.
In 14 patients with primary SUI improvement after 1 year was found in 71.4% of patients.
Although cure rates after MUS are up to 90% there is still place for less invasive treatment option like periurethral injection of bulking agents, especially in patients with previous SUI surgical management.
American Psychological Association (APA)
Futyma, Konrad& Miotła, Paweł& Gałczyński, Krzysztof& Baranowski, Włodzimierz& Doniec, Jacek& Wodzisławska, Agnieszka…[et al.]. 2015. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation. BioMed Research International،Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1056999
Modern Language Association (MLA)
Futyma, Konrad…[et al.]. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation. BioMed Research International No. 2015 (2015), pp.1-5.
https://search.emarefa.net/detail/BIM-1056999
American Medical Association (AMA)
Futyma, Konrad& Miotła, Paweł& Gałczyński, Krzysztof& Baranowski, Włodzimierz& Doniec, Jacek& Wodzisławska, Agnieszka…[et al.]. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1056999
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1056999